R&D expenditure of pharmaceutical companies in China 2014-2023
In China, pharmaceutical companies spent a total of 17.4 billion U.S. dollars on research and development (R&D) in 2018, showing an upward trend in recent years. With an estimated compound annual growth rate (CAGR) of 23 percent, the R&D spending by pharmaceutical companies was expected to reach almost 50 billion U.S. dollars by 2023.